Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pivotal Role of Fyn Kinase in Parkinson’s Disease and Levodopa-Induced Dyskinesia: a Novel Therapeutic Target?
Efthalia Angelopoulou, Yam Nath Paudel, Thomas Julian, et al.
Molecular Neurobiology (2020) Vol. 58, Iss. 4, pp. 1372-1391
Closed Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Therapeutic Implications of Caffeic Acid in Cancer and Neurological Diseases
Manzar Alam, Sarfraz Ahmed, Abdelbaset Mohamed Elasbali, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 140
GSK-3β, FYN, and DYRK1A: Master Regulators in Neurodegenerative Pathways
Stefania Demuro, Rita Maria Concetta Di Martino, José Antonio Ortega, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 9098-9098
Open Access | Times Cited: 60
Unraveling the Genetic Landscape of Neurological Disorders: Insights into Pathogenesis, Techniques for Variant Identification, and Therapeutic Approaches
Zeba Firdaus, Xiaogang Li
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2320-2320
Open Access | Times Cited: 11
Prion Protein: The Molecule of Many Forms and Faces
Valerija Kovač, Vladka Čurin Šerbec
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1232-1232
Open Access | Times Cited: 32
Challenges in Discovering Drugs That Target the Protein–Protein Interactions of Disordered Proteins
Judit Oláh, Tibor Szénási, Attila Lehotzky, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1550-1550
Open Access | Times Cited: 28
Emerging Potential of the Phosphodiesterase (PDE) Inhibitor Ibudilast for Neurodegenerative Diseases: An Update on Preclinical and Clinical Evidence
Efthalia Angelopoulou, Efstratios‐Stylianos Pyrgelis, Christina Piperi
Molecules (2022) Vol. 27, Iss. 23, pp. 8448-8448
Open Access | Times Cited: 28
The Non-receptor Tyrosine Kinase Pyk2 in Brain Function and Neurological and Psychiatric Diseases
Benoit de Pins, Tiago Mendes, Albert Giralt, et al.
Frontiers in Synaptic Neuroscience (2021) Vol. 13
Open Access | Times Cited: 37
Identification of novel Kv1.3 channel-interacting proteins using proximity labelling in T-cells
Dilpreet Kour, Christine A Bowen, Upasna Srivastava, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Unraveling the role of neuregulin-mediated astrocytes-OPCs axis in the pathogenesis of age-related macular degeneration and Parkinson’s disease
Shuyan Zhang, Cheng Zhang, Yinjian Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Pre-clinical evidence for mitochondria as a therapeutic target for luteolin: a mechanistic view
Marcos Roberto de Oliveira
Chemico-Biological Interactions (2025), pp. 111492-111492
Closed Access
Antioxidative role of Traditional Chinese Medicine in Parkinson's disease
Fahim Muhammad, Yan Liu, Yongtao Zhou, et al.
Journal of Ethnopharmacology (2021) Vol. 285, pp. 114821-114821
Closed Access | Times Cited: 27
GSK-3β-mediated regulation of Nrf2/HO-1 signaling as a new therapeutic approach in the treatment of movement disorders
Divya Soni, Puneet Kumar
Pharmacological Reports (2022) Vol. 74, Iss. 4, pp. 557-569
Closed Access | Times Cited: 22
Neuroprotective thiazole sulfonamides against 6-OHDA-induced Parkinsonian model: in vitro biological and in silico pharmacokinetic assessments
Waralee Ruankham, Ratchanok Pingaew, Veda Prachayasittikul, et al.
RSC Advances (2025) Vol. 15, Iss. 6, pp. 4281-4295
Open Access
Modulation of Peripheral Mast Cell and Brain Microglia Axis via Kinase Inhibition
Xiaoguang Liu, Michaeline Hebron, Kaluvu Balaraman, et al.
Metabolites (2025) Vol. 15, Iss. 3, pp. 194-194
Open Access
Neural stem cell secretome exerts a protective effect on damaged neuron mitochondria in Parkinson's disease model
Wei Ni, Jiqin Zhou, Yating Ling, et al.
Brain Research (2022) Vol. 1790, pp. 147978-147978
Closed Access | Times Cited: 15
Transcriptome and Proteome Analysis in LUHMES Cells Overexpressing Alpha-Synuclein
Matthias Höllerhage, Markus Stepath, Michael Kohl, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 14
Levodopa-induced dyskinesia: interplay between the N-methyl-D-aspartic acid receptor and neuroinflammation
Fanshi Zhang, Mei Liu, Jinmei Tuo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
The role of ACE2 in RAS axis on microglia activation in Parkinson’s disease
Tingting Liu, Jingwen Li, Lin Sun, et al.
Neuroscience (2024) Vol. 553, pp. 128-144
Closed Access | Times Cited: 2
Role of Fyn Kinase Inhibitors in Switching Neuroinflammatory Pathways
Giambattista Marotta, Filippo Basagni, Michela Rosini, et al.
Current Medicinal Chemistry (2021) Vol. 29, Iss. 27, pp. 4738-4755
Open Access | Times Cited: 16
Differential Phospho‐Signatures in Blood Cells Identify LRRK2 G2019S Carriers in Parkinson's Disease
Alícia Garrido, Enrique Santamaría, Joaquín Fernández‐Irigoyen, et al.
Movement Disorders (2022) Vol. 37, Iss. 5, pp. 1004-1015
Open Access | Times Cited: 12
Exploring the Role of ACE2 as a Connecting Link between COVID-19 and Parkinson’s Disease
Efthalia Angelopoulou, Eleni Karlafti, Vasiliki Georgakopoulou, et al.
Life (2023) Vol. 13, Iss. 2, pp. 536-536
Open Access | Times Cited: 6
Neuroinflammation and Dyskinesia: A Possible Causative Relationship?
Antonella Cardinale, Antonio de Iure, Barbara Picconi
Brain Sciences (2024) Vol. 14, Iss. 5, pp. 514-514
Open Access | Times Cited: 1
Fyn Knock-Down Prevents Levodopa-Induced Dyskinesia in a Mouse Model of Parkinson’s Disease
Melina Bordone, Ana Damianich, Alejandra Bernardi, et al.
eNeuro (2021) Vol. 8, Iss. 4, pp. ENEURO.0559-20.2021
Open Access | Times Cited: 10
Microarray Genotyping Identifies New Loci Associated with Dementia in Parkinson’s Disease
Sungyang Jo, Kye Won Park, Yun Su Hwang, et al.
Genes (2021) Vol. 12, Iss. 12, pp. 1975-1975
Open Access | Times Cited: 9
Mechano-growth factor regulates periodontal ligament stem cell proliferation and differentiation through Fyn–RhoA-YAP signaling
Fan Feng, Teng Tu, Hui Wang, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 733, pp. 150450-150450
Closed Access
Page 1 - Next Page

Scroll to top